Thymine derivatives and quinazoline-dione derivatives for the inhibition of hsp27
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- DRESDEN UNIVERSITY OF TECHNOLOGY
- Publication Date
- 2017-08-18
- Estimated Expiration
- Not applicable · inactive patent
Smart Images

Figure 1 
Figure 2 
Figure 3
Abstract
Description
technical field
[0001] The present invention relates to a novel thymine derivative and its application as medicine for selective inhibition of heat shock protein HSP27 (HSPB1). Background technique
[0002] For some cancers, the treatment with cytostatics will not be effective from the beginning. Even if the patient suffers from an easily curable cancer type, the treatment with cytostatics may fail after a period of time. One possible reason is the development of resistance, whereby tumor cells become less sensitive to cytostatics, the biological processes behind which are known.
[0003] It can be seen that the treatment of various tumor cell lines with cytostatics leads to an increase in the expression of cellular proteins, which has a great impact on the protection and stability of the correct folding of receptors, enzymes and cellular structural proteins.
[0004] Heat shock protein is an evolutionarily highly conserved protein formed by cells under sublethal stress con...